Skip to main content

Botulinum Toxin in Abdominal Wall Hernia Repair

  • Chapter
  • First Online:
The SAGES Manual of Hernia Surgery

Abstract

As surgeons are treating more complex hernias, adjuncts to aid in repair can be useful in certain situations. Botulinum toxin A (BTA) is one such adjunct that can help increase intraabdominal volume and increase ease of repair for large hernias, including those with loss of domain. The evidence for the use of BTA is increasing and thus far some benefit is seen, with minimal risk. In this chapter, we will be reviewing current evidence for the use of BTA for hernia repair, and describing our technique of administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Jankovic J. Botulinum toxin: state of the art. Mov Disord. 2017;32(8):1131–8.

    Article  CAS  Google Scholar 

  2. Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol. 2012;15(3):325–36.

    Article  Google Scholar 

  3. Dressler D, Bigalke H. Immunological aspects of botulinum toxin therapy. Expert Rev Neurother. 2017;17(5):487–94.

    Article  CAS  Google Scholar 

  4. Sethi KD, Rodriguez R, Olayinka B. Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ. 2012;15(3):419–23.

    Article  Google Scholar 

  5. Evidente VG, Truong D, Jankovic J, Comella CL, Grafe S, Hanschmann A. IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. J Neurol Sci. 2014;346(1–2):116–20.

    Article  CAS  Google Scholar 

  6. Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z. Diffusion, spread, and migration of botulinum toxin. Mov Disord. 2013;28(13):1775–83.

    Article  CAS  Google Scholar 

  7. Erbguth F, Claus D, Engelhardt A, Dressler D. Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry. 1993;56(11):1235–6.

    Article  CAS  Google Scholar 

  8. Diener MK, Voss S, Jensen K, Büchler MW, Seiler CM. Elective midline laparotomy closure: the INLINE systematic review and meta-analysis. Ann Surg. 2010;251(5):843–56.

    Article  Google Scholar 

  9. Deerenberg EB, Timmermans L, Hogerzeil DP, et al. A systematic review of the surgical treatment of large incisional hernia. Hernia. 2015;19(1):89–101.

    Article  CAS  Google Scholar 

  10. Fink C, Baumann P, Wente MN, et al. Incisional hernia rate 3 years after midline laparotomy. Br J Surg. 2014;101(2):51–4.

    Article  CAS  Google Scholar 

  11. Elstner KE, Jacombs AS, Read JW, et al. Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using botulinum toxin A. Hernia. 2016;20(2):209–19.

    Article  CAS  Google Scholar 

  12. Flum DR, Horvath K, Koepsell T. Have outcomes of incisional hernia repair improved with time? A population-based analysis. Ann Surg. 2003;237(1):129–35.

    Article  Google Scholar 

  13. Novitsky YW. Hernia surgery: current principles. Cham: Springer; 2016.

    Book  Google Scholar 

  14. Novitsky YW, Elliott HL, Orenstein SB, Rosen MJ. Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction. Am J Surg. 2012;204(5):709–16.

    Article  Google Scholar 

  15. Caldironi MW, Romano M, Bozza F, et al. Progressive pneumoperitoneum in the management of giant incisional hernias: a study of 41 patients. Br J Surg. 1990;77(3):306–7.

    Article  CAS  Google Scholar 

  16. Dumont F, Fuks D, Verhaeghe P, et al. Progressive pneumoperitoneum increases the length of abdominal muscles. Hernia. 2009;13(2):183–7.

    Article  CAS  Google Scholar 

  17. Admire AA, Dolich MO, Sisley AC, Samimi KJ. Massive ventral hernias: role of tissue expansion in abdominal wall restoration following abdominal compartment syndrome. Am Surg. 2002;68(5):491–6.

    PubMed  Google Scholar 

  18. Ibarra-Hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, Robles-Vélez E, de Jesús González-Jaime J. Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg. 2009;33(12):2553–6.

    Article  Google Scholar 

  19. Jankovic J. Botulinum toxin: therapeutic clinical practice and science. Philadelphia, PA: Saunders/Elsevier; 2009.

    Google Scholar 

  20. Cakmak M, Caglayan F, Somuncu S, et al. Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: an experimental study. J Pediatr Surg. 2006;41(4):821–5.

    Article  Google Scholar 

  21. Elstner KE, Read JW, Rodriguez-Acevedo O, et al. Preoperative chemical component relaxation using Botulinum toxin A: enabling laparoscopic repair of complex ventral hernia. Surg Endosc. 2017;31(2):761–8.

    Article  Google Scholar 

  22. Elstner KE, Read JW, Rodriguez-Acevedo O, Ho-Shon K, Magnussen J, Ibrahim N. Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair. Surg Endosc. 2017;31(4):1914–22.

    Article  Google Scholar 

  23. Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, et al. Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2017;32(2):831–9.

    Article  Google Scholar 

  24. Ibarra-Hurtado TR, Nuño-Guzmán CM, Miranda-Díaz AG, Troyo-Sanromán R, Navarro-Ibarra R, Bravo-Cuéllar L. Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia. 2014;18(5):647–52.

    Article  CAS  Google Scholar 

  25. Bueno-Lledó J, Torregrosa A, Ballester N, et al. Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia. Hernia. 2017;21(2):233–43.

    Article  Google Scholar 

  26. Zendejas B, Khasawneh MA, Srvantstyan B, Jenkins DH, Schiller HJ, Zielinski MD. Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg. 2013;37(12):2830–7.

    Article  Google Scholar 

  27. Zielinski MD, Kuntz M, Zhang X, et al. Botulinum toxin A-induced paralysis of the lateral abdominal wall after damage-control laparotomy: a multi-institutional, prospective, randomized, placebo-controlled pilot study. J Trauma Acute Care Surg. 2016;80(2):237–42.

    Article  CAS  Google Scholar 

  28. Brown SH, McGill SM. Transmission of muscularly generated force and stiffness between layers of the rat abdominal wall. Spine (Phila Pa 1976). 2009;34(2):E70–5.

    Article  Google Scholar 

  29. Durham PL, Cady R. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache. 2004;44(1):35–42; discussion 42–33.

    Article  Google Scholar 

  30. Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain. 2006;125(1–2):82–8.

    Article  Google Scholar 

  31. Childers MK, Wilson DJ, Gnatz SM, Conway RR, Sherman AK. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil. 2002;81(10):751–9.

    Article  Google Scholar 

  32. Perez D, Wildi S, Demartines N, Bramkamp M, Koehler C, Clavien PA. Prospective evaluation of vacuum-assisted closure in abdominal compartment syndrome and severe abdominal sepsis. J Am Coll Surg. 2007;205(4):586–92.

    Article  Google Scholar 

  33. Smoot D, Zielinski M, Jenkins D, Schiller H. Botox A injection for pain after laparoscopic ventral hernia: a case report. Pain Med. 2011;12(7):1121–3.

    Article  Google Scholar 

  34. Weum S, de Weerd L. Perforator-guided drug injection in the treatment of abdominal wall pain. Pain Med. 2016;17(7):1229–32.

    Article  Google Scholar 

  35. Dressler D, Adib Saberi F, Bigalke H. IncobotulinumtoxinA (Xeomin(®)) can produce antibody-induced therapy failure in a patient pretreated with abobotulinumtoxinA (Dysport(®)). J Neural Transm (Vienna). 2014;121(7):769–71.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Talar Tejirian M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tejirian, T., Yeung, L. (2019). Botulinum Toxin in Abdominal Wall Hernia Repair. In: Davis, Jr., S., Dakin, G., Bates, A. (eds) The SAGES Manual of Hernia Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-78411-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78411-3_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78410-6

  • Online ISBN: 978-3-319-78411-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics